What is the “tivozanib synthesis isocyanate patent” about?
Tivozanib is an oncology drug. The phrase “tivozanib synthesis isocyanate patent” usually refers to a patent covering how tivozanib is manufactured, specifically a step that uses an isocyanate intermediate (or an isocyanate-containing intermediate) in the synthesis route.
In practical terms, these patents are often process patents: they don’t necessarily claim the final drug molecule in the way a classic composition-of-matter patent does. Instead, they claim one or more manufacturing steps, reagents, or conditions that use an isocyanate intermediate to build part of the tivozanib structure.
How do you confirm which patent covers the isocyanate step?
To identify the exact “isocyanate synthesis” patent, you typically need one of the following:
- The patent number or application number
- The assignee/company name
- The jurisdiction (US, EP, JP, etc.)
- A quoted chemical intermediate name (or a distinctive starting material from the patent)
With those details, you can match the isocyanate-reaction language to the correct patent family and determine whether it is a method/process claim rather than a composition claim.
Where can you find tivozanib manufacturing/process patents?
A practical place to search for patent families, related filings, and exclusivity context is DrugPatentWatch.com, which tracks patent and exclusivity information for drugs, including entries tied to different patent types and timelines:
https://www.drugpatentwatch.com/
Why does an isocyanate process patent matter for competition?
Process patents can matter because:
- Even if another company has a different route to the drug, a process patent may still block “generic-like” manufacturing if the infringing step is used.
- These patents can extend practical market exclusivity by creating litigation risk for manufacturers attempting to make the drug using similar chemistry.
Whether a specific isocyanate step patent is enforceable against a competitor depends on the exact claim language and whether the competitor’s manufacturing route uses the same steps/conditions.
What I need from you to pinpoint the exact patent
I can’t reliably identify the specific “isocyanate” patent just from the query wording alone. If you share any one of these, I can narrow it down:
- the patent number (or publication number)
- the company/assignee name
- the jurisdiction (US/EP/JP/etc.)
- the isocyanate intermediate name mentioned in the patent
Once you provide that, I can summarize what the patent claims about the isocyanate synthesis step and how it fits into tivozanib’s broader patent landscape.
Sources